Clinical trial

ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)

NCT00140907

Study summary

ClinicalTrials.gov

ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record losartan potassium Normalized identity: losartan potassium View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Comparator: Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-03-14

PhasePHASE4

Conditions

High Blood Pressureverified · MONDO: hypertensive disorder

Interventions

losartan potassiumDRUG · verified · RxNorm: losartan potassium

Comparator: PlaceboDRUG

Sponsors & collaborators

Organon and Colead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00140907 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.